NP
RVNC

NorthRock Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History

NorthRock Partners’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,162
Closed -$129K – 869
2024
Q2 		$129K Buy
50,162
+19,454
+63% +$50K ﹤0.01% 599
2024
Q1 		$151K Buy
+30,708
New +$151K 0.01% 603